Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 3,760 |
| Receivables | 0 | 0 | 540 |
| Other current assets | 0 | 0 | 520 |
| TOTAL | $0 | $0 | $4,820 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 4,540 |
| Other Non-Current Assets | 0 | 0 | 10 |
| TOTAL | $N/A | $N/A | $4,550 |
| Total Assets | $0 | $0 | $7,270 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 0 | 0 | 200 |
| Accounts payable and accrued liabilities | 0 | 0 | 270 |
| Accrued Expenses | 0 | 0 | 550 |
| Other current liabilities | 0 | 0 | 700 |
| TOTAL | $0 | $0 | $1,760 |
| Non-Current Liabilities | |||
| Long Term Debt | 0 | 0 | 1,440 |
| Other Non-Current Liabilities | 0 | 0 | 3,460 |
| TOTAL | $N/A | $N/A | $4,900 |
| Total Liabilities | $0 | $0 | $6,690 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 10 |
| Retained earnings | 0 | 0 | -55,950 |
| Other shareholders' equity | 0 | 0 | -1,080 |
| TOTAL | $0 | $0 | $580 |
| Total Liabilities And Equity | $0 | $0 | $7,270 |